Glyburide: caution for efficacy and fetal programming effects.
Ross
Michael G
MG
Kjos
Siri L
SL
D000273:Adipose Tissue / Q000187:drug effects* / Q000196:embryology*; D001724:Birth Weight / Q000187:drug effects; D016640:Diabetes, Gestational / Q000188:drug therapy*; D005260:Female; D047109:Fetal Development / Q000187:drug effects; D005905:Glyburide / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D007231:Infant, Newborn; D011247:Pregnancy
D007004:Hypoglycemic Agents; D005905:Glyburide